Primrose Bio Launches Prima RNApols™ ExTend Cap AU, a Next-Gen RNA Polymerase for Self-Amplifying mRNA
Maximize capping efficiency and minimize double-stranded RNA (“dsRNA”) in the manufacturing of self-amplifying mRNA Primrose Bio, Inc. (“Primrose”), a company with proprietary therapeutic manufacturing technologies, today announced the launch of PrimaRNApols™ExTend Cap AU, an RNA polymerase engineered to significantly improve manufacturing of self-amplifying mRNA vaccines and therapeutics. https://mma.prnewswire.com/media/2214146/Primrose_Bio_Logo.jpg ExTend Cap AU enables high-yield, fully capped […]